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In the previous issue of Critical Care, Lucidarme and 
colleagues [1] describe the impact of nicotine abstinence 
on the clinical course of critically ill patients receiving 
mechanical ventilation for at least 48 hours. Th  eir  study 
included 144 patients, 44 smokers and 100 non-smokers. 
Th  e smokers were more likely to be younger and male, 
have a history of alcoholism, and be admitted for septic 
shock compared to non-smokers. Th   e results of the study 
showed active smoking history to be an independent risk 
factor for agitation.
Lucidarme and colleagues address an important clinical 
issue intensivists face daily in our practice. Th   ere are 1.2 
billion smokers in the world, half of whom will die from 
diseases caused by smoking [2]. Tobacco products are 
highly addictive [3,4] and abstinence from their use in 
active smokers can lead to withdrawal symptoms [5,6]. 
Th  ese symptoms are often non-life threatening and are 
not well described in the critically ill. Mayer and colla-
bora  tors [7] reported ﬁ  ve cases of agitated delirium in 
smokers hospitalized for brain injury. Th   ey attributed the 
delirium to nicotine withdrawal because of its improve-
ment following nicotine replacement therapy (NRT). 
Tran-Van and colleagues [8] reported a case with diﬃ   -
culty to wean from mechanical ventilation, and restless-
ness attributed to nicotine withdrawal. Th  e patient’s 
condition improved following NRT.
Because of several confounding factors, it is diﬃ   cult to 
determine the exact incidence of nicotine withdrawal in 
critically ill smokers. Critical illness, mechanical ventila-
tion, and sepsis can be associated with various levels of 
encephalopathy. Th   e symptoms and signs of the encepha-
lo  pathy may mimic the manifestations of nicotine 
withdrawal. Moreover, smokers may also have other 
addic  tions, including alcohol and illicit drugs. Th  e  mani-
festa  tions of abstinence from such addictive substances 
may not be easily distinguishable from the manifestations 
of nicotine withdrawal. Although compromised by the 
small sample size, Lucidarme and colleagues [1] have 
done their best to minimize the impact of confounding 
factors by matching cases and controls.
Th   ere is a scarcity of data addressing the presence and 
extent of clinically important nicotine withdrawal symp-
toms in critically ill active smokers. Th  e study by 
Lucidarme and colleagues is one step towards this. Since 
the symptoms and signs of nicotine withdrawal lack 
speciﬁ   city in the critically ill, eﬀ   ective therapy aimed 
speciﬁ   cally at preventing and treating nicotine with-
drawal, with no eﬀ  ect on other conditions with similar 
manifestations, may help to deﬁ  ne the clinical course of 
nicotine withdrawal in the critically ill. Th  e major 
currently available treatment options for nicotine addic-
tion include NRT, bupropion, and varenicline. Several 
studies performed mostly in the outpatient setting have 
shown that NRT is safe and eﬀ   ective in ameliorating 
symptoms of nicotine withdrawal [9]. Although data 
justifying the use of NRT in the critically ill are non-
existent, some ICUs have developed protocols oﬀ  ering it 
to all active smokers [10]. We recognize that hospitali-
zation provides an excellent opportunity to intervene on 
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intervention. Although the study was compromised by 
several limitations, our groups have shown that NRT may 
be associated with increased mortality in the critically ill 
[10]. A similar association was reported in patients 
under  going cardiac surgery [11]. We have recently 
completed a prospective, cohort study of active smokers 
admitted to a medical ICU [12]. Th   e study did not show 
statistically signiﬁ   cant association between NRT and 
mortality. However, NRT did not reduce the development 
of delirium.
Since nicotine addiction is a global health problem, 
some healthcare providers treat critically ill active 
smokers with NRT. Th  eoretically, this approach may be 
beneﬁ  cial to critically ill smokers whose clinical course 
may be complicated by nicotine withdrawal. However, 
the clinical impact of nicotine withdrawal in the critically 
ill has not been well described. Although there are case 
reports suggesting that prevention and treatment of 
nicotine withdrawal may be beneﬁ  cial [7,8], retrospective 
studies have shown nicotine replacement therapy may 
increase mortality in the critically ill [10,11]. Future 
studies are warranted to describe the incidence and 
clinical manifestations of nicotine withdrawal. Moreover, 
interventions aimed at the prevention and treatment of 
nicotine withdrawal in the critically ill should be sub-
jected to clinical trials before applying them to patients.
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